CTAD24 | Clinical Trials on Alzheimer’s Disease Madrid, Spain | 29 October – 1 November 2024 Be the first to gain access to new data and insights, presented at CTAD24. Access Posters This year at CTAD, we can’t wait to share our latest research with you. There will be four posters, with Michael Spilka, PhD […]
CTAD24 | Clinical Trials on Alzheimer’s Disease Read More »
Revolutionizing Clinical Trial Central Monitoring: Automated Quality Assurance for Faster, Scalable Monitoring by Rachel Newsome, PhD Tuesday 22nd October at 15:45 Accurate administration of rater-based clinical instruments, such as the Clinical Dementia Rating (CDR), is critical for reliable clinical outcomes in Alzheimer’s Disease (AD) trials. However, existing gold-standard quality assurance (QA) processes rely heavily or
Clinical Trials Innovation Summit 2024 Read More »
